Doctor profile · Federal record
Dr. Melissa McShane, M.D.
Medical Oncology Physician (CMS: Hematology/Oncology) · Student in an Organized Health Care Education/Training Program · Philadelphia, PA
- NPI 1578980462
- Accepts Medicare
- MIPS 72.5 / 100 · 2023
- 12 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
333 Cottman Ave
Philadelphia, PA 191112434
(215) 728-6900
fax (215) 728-3639
Credentials & registration
- NPI registered
- March 2014 — 12 yrs on file
- Profile last updated
- October 2, 2024
- Year of graduation
- 2014 — 12 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Pennsylvania #MD467216
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1578980462. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
328
Distinct HCPCS
4
Medicare allowed
$41,328
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 163 | 55 | $149 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 120 | 64 | $101 | |
G2212 |
Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 23 | 14 | $32 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 22 | 22 | $189 |
In context: peer comparison
Among 48 peers in Philadelphia Medical Oncology Physician, average services per provider: 121. This provider delivers 2.7× the peer median.Open Payments
Industry payments received
All-time total
$5,810
Transactions
7
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 5 | $5,704.79 | |
| Daiichi Sankyo INC. | 1 | $83.46 | |
| Genentech USA, INC. | 1 | $21.90 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
327
Patients
74
Total drug cost
$216,323
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Anastrozole | Generic | 120 | 31 | $3,128 |
| Letrozole | Generic | 66 | 21 | $1,916 |
| Ondansetron Hcl | Generic | 31 | 11 | $195 |
| Tamoxifen Citrate | Generic | 27 | 0 | $970 |
| Exemestane | Generic | 26 | 0 | $4,425 |
| Dexamethasone | Generic | 18 | 11 | $257 |
| Ibrance (Palbociclib) | Brand | 14 | 0 | $205,274 |
| Lorazepam | Generic | 13 | 0 | $76 |
| Tramadol Hcl | Generic | 12 | 0 | $82 |
Hospital affiliations
Frequently asked questions
What is Dr. Melissa McShane's medical specialty?
Dr. Melissa McShane practices Medical Oncology Physician in Philadelphia, PA.
Where does Dr. Melissa McShane practice?
Dr. Melissa McShane practices at 333 Cottman Ave, Philadelphia, PA 191112434. Office phone: 2157286900.
What is Dr. Melissa McShane's NPI?
Dr. Melissa McShane's National Provider Identifier (NPI) is 1578980462, issued by NPPES.
Does Dr. Melissa McShane accept Medicare assignment?
Yes. Dr. Melissa McShane accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Melissa McShane commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99214); Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS G2212). Source: CMS Medicare Physician & Other Practitioners file.